2018
DOI: 10.4067/s0034-98872018001201422
|View full text |Cite
|
Sign up to set email alerts
|

Rendimiento diagnóstico de marcadores tumorales séricos convencionales en pacientes con sospecha clínica de cáncer primario metastásico a hígado

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 6 publications
0
1
0
1
Order By: Relevance
“…AFP and CA199 are commonly used tumor markers for the diagnosis of liver cancer. Although the detection of the two marker levels is simple, the detection sensitivity and specificity are not high [ 27 , 28 ]. Therefore, missed diagnosis can easily occur because these two serum markers are highly expressed not only in liver cancer patients, but also in many other malignant tumors.…”
Section: Discussionmentioning
confidence: 99%
“…AFP and CA199 are commonly used tumor markers for the diagnosis of liver cancer. Although the detection of the two marker levels is simple, the detection sensitivity and specificity are not high [ 27 , 28 ]. Therefore, missed diagnosis can easily occur because these two serum markers are highly expressed not only in liver cancer patients, but also in many other malignant tumors.…”
Section: Discussionmentioning
confidence: 99%
“…En cuanto a los exámenes de laboratorio que se indican para estos casos: la biometría hemática muestra cifras bajas de hemoglobina (anemia), la eritrosedimentación está acelerada; salen alteradas las pruebas de función hepática y renal, el coagulograma, sobre todo si hay lesión hepática metastásica y la lámina periférica, por presencia de células malignas. (7,8) Los marcadores tumorales en sangre, por su parte, no solo orientan hacia el diagnóstico de neuroblastoma ya que indican la presencia de esta enfermedad, sino que, luego del tratamiento, se indican con valor pronóstico en el seguimiento de los pacientes para detectar recaídas o recidivas tumorales: (9,10) • LDH > 500 U/L…”
Section: • Dolores óSeos O Muscularesunclassified